ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RARE GlobeNewswire March 07, 2026 NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) […]

GDP growth of 4.5 percent to 5 percent, while striving for better results in practice – this is one of the main development targets for this year outlined in the Government Work Report. Economic growth targets have long attracted close attention. Over the past three years, China set its GDP growth target at around 5

Baltimore, MD, March 06, 2026 (GLOBE NEWSWIRE) — Former CIA advisor Jim Rickards has released a new video presentation examining what he believes could become a defining economic theme as the United States approaches its 250th anniversary: the push to rebuild America's industrial and resource base. In the newly released presentation, Rickards explains why natural

Former Pentagon Advisor Jim Rickards Releases New Presentation on America's Race to Rebuild Its Resource Supply The presentation explores why natural resources, energy, and manufacturing are suddenly back at the center of the U.S. economy GlobeNewswire March 07, 2026 Baltimore, MD, March 06, 2026 (GLOBE NEWSWIRE) — Former CIA advisor Jim Rickards has released a

(NASDAQ:SLNO), SAN DIEGO, March 06, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers of Soleno Therapeutics, Inc. (NASDAQ: SLNO) common stock between March 26, 2025 and November 4, 2025, inclusive (the “Class Period”), have until May 5, 2026 to seek appointment as lead plaintiff of the Soleno class action lawsuit.

Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Soleno Therapeutics, Inc., Announces Opportunity for Investors with Substantial Losses to Lead Soleno Class Action Lawsuit GlobeNewswire March 07, 2026 SAN DIEGO, March 06, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers of Soleno Therapeutics, Inc. (NASDAQ: SLNO) common

Los Angeles, CA, March 06, 2026 (GLOBE NEWSWIRE) — This article contains affiliate links. If a purchase is made through these links, a commission may be earned at no additional cost to the buyer. This article is an informational overview and does not constitute medical or health advice. All product details described below are stated

FluffCo Luxury Hotel Pillow Claims Evaluated: 2026 Consumer Report on 5-Star Hotel Pillow Marketing, Materials, Pricing Transparency, and What Buyers Should Verify Before Ordering Latest 2026 consumer report examining FluffCo Luxury Hotel Pillow marketing claims, sanforized cotton construction, down alternative fill materials, customer survey statistics, pricing structure, and the “same pillow used in 5-star hotels”

(NASDAQ:EOSE), SAN DIEGO, March 06, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Eos Energy Enterprises, Inc. (NASDAQ: EOSE) securities between November 5, 2025 and February 26, 2026, inclusive (the “Class Period”), have until May 5, 2026 to seek appointment as lead plaintiff of the Eos Energy

INVESTOR ALERT: Eos Energy Enterprises, Inc. Investors with Substantial Losses Have Opportunity to Lead the Eos Energy Class Action Lawsuit – RGRD Law GlobeNewswire March 07, 2026 SAN DIEGO, March 06, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Eos Energy Enterprises, Inc. (NASDAQ: EOSE) securities between